Table 2.
14 bp genotypic frequencies.
| Normotensive | Preeclampsia | Normotensive vs. preeclampsia | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Polymorphisms | HIV- (n = 74) |
HIV+ (n = 60) |
HIV- vs. HIV+ OR (95%), P value |
HIV- (n = 34) |
HIV+ (n = 25) |
HIV- vs. HIV+ OR (95%), P value |
HIV- EOPE (n = 13) |
HIV+ EOPE (n = 19) |
HIV- vs. HIV + OR (95%), P value |
HIV- LOPE (n = 21) |
HIV+ LOPE (n = 6) |
HIV- LOPE vs. HIV+ LOPE OR (95%), P value |
HIV+ normotensive vs. HIV+ PE OR (95%), P value |
HIV- normotensive vs. HIV- PE OR (95%), P value |
| Del/Del Del/Del vs. Ins/Ins |
33 (44.59%) | 20 (33.33%) | 2.567 (0.97–1.84) P = 0.06 |
14 (41.17%) | 7 (28%) | 25.13 (1.24–509.5) P = 0.004∗ |
8 (61.53%) | 5 (26.31%) | 20.09 (0.93–433.1) P = 0.01∗ |
6 (28.57%) | 2 (33.33%) | — | 1.22 (0.34–1.95) P = 0.76 |
8.22 (0.45–151.0) P = 0.06 |
| Ins/Ins Ins/Ins vs. Del/Ins |
9 (12.16%) | 14 (23.33%) | 1.92 (0.91–1.59) P = 0.192 |
0 (0%) | 6 (24%) | 21.32 (1.71–4.17) P = 0.005∗∗ |
0 (0%) | 6 (31.57%) | 8.41 (0.39–181.3) P = 0.08 |
0 (0%) | 0 (0%) | — | 1.08 (0.33–3.49) P = 0.82 |
13.44 (0.722–249.9) P = 0.02∗ |
| Del/Ins Del/Del vs. Del/Ins |
32 (43.24%) | 26 (43.33%) | 1.34 (0.63–2.87) P = 0.45 |
20 (58.82%) | 12 (48%) | 1.20 (0.37–3.81) P = 0.45 |
5 (38.46) | 8 (42.10%) | 2.50 (0.53–12.44) P = 0.24 |
15 (71.42%) | 4 (66.66%) | 1.25 (0.18–8.73) P = 0.82 |
1.32 (0.44–3.96) P = 0.62 |
2.95 (1.10–7.920) P = 0.03∗ |
Asterisks denote significance: ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001. Del=deletion, Ins=insertion, HIV-=HIV uninfected, HIV+=HIV infected, EOPE=early-onset preeclampsia, and LOPE=late-onset preeclampsia.